InvestorsHub Logo
Followers 163
Posts 12880
Boards Moderated 1
Alias Born 01/26/2016

Re: doingmybest post# 63414

Tuesday, 05/31/2016 5:01:09 PM

Tuesday, May 31, 2016 5:01:09 PM

Post# of 699498
doingmybest,

What if, as I have come to believe possible from what I know about the equipment, process and NWBO's unique advanced understanding of DC maturation, there was an "unexpected" improvement in therapeutic outcome found in those who received treatment from the closed system process in the U.S.? Now suppose the Europeans first challenged then more recently approved it's use then indicated last week that they would accept the patent when the translations for final approval are accepted. Then on top of all of this the Europeans wanted proof of approved manufacturing capacity because they are extremely confident from what they have seen, ie expanded access, and their long history of DC research, that there will be high demand due to Doctor awareness and advocacy at large German hospitals.
This is purely speculative on my part but I believe the way Cognate improved selectivity of DCs from other cells with the closed system process actually creates a more potent DC and may have been done "accidently on purpose" to create a "suspicion is not proof of guilt" improvement. Kind of like using underinflated footballs in the playoffs. The time that has passed may just be the German process with a little frown added in from the "unexpected benefit" and nod of approval with the patent grant. This may be another part of the reason why all patients seem to be living longer and are creating the type of situation you have envisioned.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News